Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
Change company Symbol lookup
Select an option...
CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
FR First Industrial Realty Trust Inc
PNI PIMCO New York Municipal Income Fund II
NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN
DG Dollar General Corp
SPCO Stephan Co
KEX Kirby Corp
GM General Motors Co
F Ford Motor Co
MSFT Microsoft Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Closing Price
$0.76
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.78
Day's Low
0.5088
Volume
(Above Average)
Volume:
1,592

10-day average volume:
1,592
1,592

SHAREHOLDER UPDATE: Halper Sadeh LLP Investigates PCSB, CVET, VMW, CTT

11:20 pm ET June 1, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:CVET),(NYSE:VMW),(NYSE:CTT),(NASDAQ:PCSB), EQNX::TICKER_END Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

PCSB Financial Corporation (NASDAQ: PCSB)'s sale to Brookline Bancorp, Inc. Under the terms of the merger agreement, PCSB shareholders will receive, for each share of PCSB, at the holder's election, either $22.00 in cash consideration or 1.3284 shares of Brookline common stock for each share of PCSB common stock. If you are a PCSB shareholder, click here to learn more about your rights and options.

Covetrus, Inc. (NASDAQ: CVET)'s sale to funds affiliated with Clayton, Dubilier & Rice and TPG Capital for $21.00 per share in cash. If you are a Covetrus shareholder, click here to learn more about your rights and options.

VMware, Inc. (NYSE: VMW)'s sale to Broadcom Inc. Under the terms of the merger, VMware shareholders may elect to receive either $142.50 in cash or 0.2520 shares of Broadcom common stock for each share of VMware they own. The shareholder election is subject to proration. If you are a VMware shareholder, click here to learn more about your rights and options.

CatchMark Timber Trust, Inc. (NYSE: CTT)'s sale to PotlatchDeltic Corporation for 0.23 common shares of PotlatchDeltic stock for each common share of CatchMark. If you are a CatchMark shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

https://ml.globenewswire.com/media/5dbbadd8-4d10-4402-b700-103223bb4248/small/firm-logo-with-investor-law-firm-jpg.jpg

https://ml.globenewswire.com/media/5dbbadd8-4d10-4402-b700-103223bb4248/small/firm-logo-with-investor-law-firm-jpg.jpg

comtex tracking

COMTEX_408077689/2010/2022-06-01T23:20:43

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.